Lyell Immunopharma, Inc. (LYEL)
28.00
-2.78
(-9.03%)
USD |
NASDAQ |
Jan 02, 12:37
Lyell Immunopharma Market Cap: 414.63M for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 37.29B |
| Nektar Therapeutics | 730.08M |
| GT Biopharma, Inc. | 8.877M |
| Ionis Pharmaceuticals, Inc. | 12.93B |
| Regeneron Pharmaceuticals, Inc. | 81.09B |
Market Cap Related Metrics
| PS Ratio | 101533.7 |
| PEG Ratio | -0.0006 |
| Price to Book Value | 1.260 |
| Price | 28.00 |
| Earnings Yield | -69.97% |
| PEGY Ratio | -0.0006 |